Chad Landon Garmany

Chad Garmany practices at Mercy Hospital Oklahoma City in Oklahoma City, Oklahoma, part of Mercy.

Chad Garmany's NPI, 1407019219, was assigned on July 2, 2008. Chad Garmany holds Oklahoma license 26511.

Chad Garmany's primary practice is Mercy Hospital Oklahoma City, at 4300 West Memorial Road, Oklahoma City, OK 73120 in Oklahoma County. The practice phone is (405) 755-1515.

Chad Garmany's primary practice is Mercy Hospital Oklahoma City in Oklahoma City, Oklahoma, part of Mercy. Chad Garmany is also affiliated with Oklahoma Heart Hospital North. The medical group on file is Mercy Clinic Oklahoma Communities. Dmand AI also links Chad Garmany to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Chad Garmany practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Chad Garmany's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Chad Garmany is licensed in Oklahoma.

CMS data shows 288 Medicare services from Chad Garmany across 2 procedure codes in 2024, for 290 Medicare patients. Medicare paid $32,682 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 290 Medicare patients who saw Chad Garmany in 2024. The largest group is 75 to 84, with 117 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Chad Garmany's median patient age at 71, with 56% women.

Chad Garmany accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Chad Garmany. Chad Garmany's most frequent co-authors are Sarah Elizabeth Andrews, MD, Sarah Andrews, DO and Martina Jan Jelley, MD.

CMS Open Payments shows 10 general payments to Chad Garmany from 6 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $59.